SAREPTA INTERNATIONAL UK LTD.
ActiveKey figures
Like most small UK companies, SAREPTA INTERNATIONAL UK LTD. does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024Sector comparison
SIC 21200Where the company stands among the 519 active companies whose first SIC code is 21200 (Manufacture of pharmaceutical preparations).
- GLAXO OPERATIONS UK LIMITED£1.1bn
- JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED£465.3m
- TEVA PHARMA HOLDINGS LIMITED£369.8m
- NAPP PHARMACEUTICAL HOLDINGS LIMITED£322.1m
- ACTAVIS HOLDINGS UK II LIMITED£278.8m
- CURIA GLOBAL HOLDINGS LIMITED£204.6m
- TEVA UK LIMITED£191.5m
- CATALENT CTS (EDINBURGH) LIMITED£162m
- NAPP PHARMACEUTICAL GROUP LIMITED£135.3m
- TEVA NI LIMITED£114.3m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 519. The line on each bar marks the median.
Summary: SAREPTA INTERNATIONAL UK LTD.
What kind of company is it?
SAREPTA INTERNATIONAL UK LTD. is a private limited company registered with Companies House under company number 10987747. It was incorporated on 29 Sep 2017. Its status is active. The registered office is in Reading (RG1). Its nature of business (SIC 2007) is manufacture of pharmaceutical preparations (21200), wholesale of pharmaceutical goods (46460).
How is the company doing financially?
The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files small company accounts. Net assets were £214,633, up 109.1% on the previous year. Cash at bank and in hand was £2,269,079. The company had an average of 11 employees. Figures are available for 4 financial years (2019–2024).
How does it compare with similar companies?
Compared with 519 active companies whose first SIC code is 21200: By net assets it ranks higher than 55% of them (median £63,413). By total assets it ranks higher than 79% of them (median £301,298). By cash it ranks higher than 86% of them (median £77,420). By number of employees it ranks higher than 81% of them (median 2). It is older than 53% of them (median age 8.2 years).
Who runs and controls the company?
The company has 1 current director. One person with significant control is registered.
When are its next filings due?
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 26 Oct 2027.
Filed accounts2019–2024
| 2019 | 2021 | 2023 | 2024 | |
|---|---|---|---|---|
| Cash at bank and in hand | 1,591,271 | 1,107,930 | 1,006,798 | 2,269,079 |
| Total assets | 1,770,719 | 4,345,790 | 7,847,110 | 5,925,315 |
| Total liabilities | — | — | — | — |
| Net assets / total equity | 84,185 | -668,200 | -2,360,820 | 214,633 |
| Average number of employees | 5 | 10 | 13 | 11 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
History
19 events- Financial year 2024 endedAccounts: net assets £214.6k, 11 employees
- Sharon Louise STANDERWICK resignedDirector
- Financial year 2023 endedAccounts: net assets −£2.4m, 13 employees
- Financial year 2021 endedAccounts: net assets −£668.2k, 10 employees
- Laura GENATOSSIO resignedDirector
- Laura GENATOSSIO appointedDirector
- Matthew Garrett GALL resignedDirector
- Financial year 2019 endedAccounts: net assets £84.2k, 5 employees
Earlier events (11)
- Enrico Maria DOLFINI resignedDirector
- Sharon Louise STANDERWICK appointedDirector
- Andrew ROBERTSON resignedDirector
- Enrico Maria DOLFINI appointedDirector
- Heidy ABREU resignedDirector
- Joseph BRATICA appointedDirector
- Heidy ABREU appointedDirector
- Matthew Garrett GALL appointedDirector
- Andrew ROBERTSON appointedDirector
- Sarepta Therapeutics, Inc registered as a person with significant control
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.